Cargando…
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926828/ https://www.ncbi.nlm.nih.gov/pubmed/33672366 http://dx.doi.org/10.3390/pharmaceutics13020291 |
_version_ | 1783659552041861120 |
---|---|
author | Bhia, Mohammed Motallebi, Mahzad Abadi, Banafshe Zarepour, Atefeh Pereira-Silva, Miguel Saremnejad, Farinaz Santos, Ana Cláudia Zarrabi, Ali Melero, Ana Jafari, Seid Mahdi Shakibaei, Mehdi |
author_facet | Bhia, Mohammed Motallebi, Mahzad Abadi, Banafshe Zarepour, Atefeh Pereira-Silva, Miguel Saremnejad, Farinaz Santos, Ana Cláudia Zarrabi, Ali Melero, Ana Jafari, Seid Mahdi Shakibaei, Mehdi |
author_sort | Bhia, Mohammed |
collection | PubMed |
description | Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers. |
format | Online Article Text |
id | pubmed-7926828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79268282021-03-04 Naringenin Nano-Delivery Systems and Their Therapeutic Applications Bhia, Mohammed Motallebi, Mahzad Abadi, Banafshe Zarepour, Atefeh Pereira-Silva, Miguel Saremnejad, Farinaz Santos, Ana Cláudia Zarrabi, Ali Melero, Ana Jafari, Seid Mahdi Shakibaei, Mehdi Pharmaceutics Review Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers. MDPI 2021-02-23 /pmc/articles/PMC7926828/ /pubmed/33672366 http://dx.doi.org/10.3390/pharmaceutics13020291 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bhia, Mohammed Motallebi, Mahzad Abadi, Banafshe Zarepour, Atefeh Pereira-Silva, Miguel Saremnejad, Farinaz Santos, Ana Cláudia Zarrabi, Ali Melero, Ana Jafari, Seid Mahdi Shakibaei, Mehdi Naringenin Nano-Delivery Systems and Their Therapeutic Applications |
title | Naringenin Nano-Delivery Systems and Their Therapeutic Applications |
title_full | Naringenin Nano-Delivery Systems and Their Therapeutic Applications |
title_fullStr | Naringenin Nano-Delivery Systems and Their Therapeutic Applications |
title_full_unstemmed | Naringenin Nano-Delivery Systems and Their Therapeutic Applications |
title_short | Naringenin Nano-Delivery Systems and Their Therapeutic Applications |
title_sort | naringenin nano-delivery systems and their therapeutic applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926828/ https://www.ncbi.nlm.nih.gov/pubmed/33672366 http://dx.doi.org/10.3390/pharmaceutics13020291 |
work_keys_str_mv | AT bhiamohammed naringeninnanodeliverysystemsandtheirtherapeuticapplications AT motallebimahzad naringeninnanodeliverysystemsandtheirtherapeuticapplications AT abadibanafshe naringeninnanodeliverysystemsandtheirtherapeuticapplications AT zarepouratefeh naringeninnanodeliverysystemsandtheirtherapeuticapplications AT pereirasilvamiguel naringeninnanodeliverysystemsandtheirtherapeuticapplications AT saremnejadfarinaz naringeninnanodeliverysystemsandtheirtherapeuticapplications AT santosanaclaudia naringeninnanodeliverysystemsandtheirtherapeuticapplications AT zarrabiali naringeninnanodeliverysystemsandtheirtherapeuticapplications AT meleroana naringeninnanodeliverysystemsandtheirtherapeuticapplications AT jafariseidmahdi naringeninnanodeliverysystemsandtheirtherapeuticapplications AT shakibaeimehdi naringeninnanodeliverysystemsandtheirtherapeuticapplications |